EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cord Blood–Derived Endothelial Progenitor Cells Promote In Vivo Regeneration of Human Hematopoietic Bone Marrow

Phuong L Doan, Anne C Frei, Sadhna O Piryani, Nathan Szalewski, Elizabeth Fan, Heather A Himburg

International Journal of Radiation Oncology*Biology*Physics · 2023-08 · 116 (5) · 1163-1174

DOI: 10.1016/j.ijrobp.2023.02.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2023-08. Verfasst von Phuong L Doan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy; Duke Cancer Institute, Duke University, Durham, North Carolina. Hauptthemen laut MEDLINE: Endothelial Progenitor Cells, Acute Radiation Syndrome, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Duke Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Victims of acute radiation exposure are susceptible to hematopoietic toxicity due to bone marrow damage and loss of mature blood elements. Here, we evaluated cord blood-derived endothelial progenitor cells (CB-EPCs) as a potential cellular therapy for mitigation of hematologic acute radiation syndrome. CB-EPCs express endothelial cell markers and maintain their growth characteristics beyond 10+ passages without diminishing their doubling capacity. Further, CB-EPCs can be cryopreserved in vapor-phase liquid nitrogen and easily recovered for propagation, making them an attractive nonimmunogenic cellular therapy for off-the-shelf use. Importantly, we show CB-EPCs have the capacity to potently expand adult human bone marrow hematopoietic progenitor cells both in vitro and in vivo. METHODS AND MATERIALS: To demonstrate the role of CB-EPCs in promoting in vivo human immune reconstitution after irradiation, we employed a novel humanized mouse model established by transplant of CD34+ bone marrow cells from 9 unique adult organ donors into immunocompromised NSG-SGM3 mice. The response of the humanized immune system to ionizing irradiation was then tested by exposure to 1 Gy followed by subcutaneous treatment of CB-EPCs, Food and Drug Administration-approved growth factor pegfilgrastim (0.3 mg/kg), or saline. RESULTS: At day 7, total human bone marrow was decreased by 80% in irradiated controls. However, treatment with either growth factor pegfilgrastim or CB-EPCs increased recovery of total human bone marrow by 2.5-fold compared with saline. Notably, CB-EPCs also increased recovery of both human CD34+ progenitors by 5-fold and colony-forming capacity by 3-fold versus saline. Additionally, CB-EPCs promoted recovery of endogenous bone marrow endothelial cells as observed by both increased vessel area and length compared with saline. CONCLUSIONS: These findings indicate the feasibility of using humanized mice engrafted with adult bone marrow for radiation research and the development of CB-EPCs as an off-the-shelf cellular therapy for mitigation of hematologic acute radiation syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial Progenitor CellsAcute Radiation SyndromeHematopoietic Stem Cell TransplantationAdultHumansMiceAnimalsBone MarrowHematopoietic Stem CellsFetal BloodBone Marrow CellsIntercellular Signaling Peptides and Proteins

Substanzen

Intercellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy; Duke Cancer Institute, Duke University, Durham, North Carolina.
  • Department of Radiation Oncology.
  • Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy.
  • Department of Radiation Oncology; Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: hhimburg@mcw.edu.

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Duke Cancer Institute
  • National Institutes of Health
  • Duke University
  • Medical College of Wisconsin

Zitieren

APA

Doan, P. L., Frei, A. C., Piryani, S. O., Szalewski, N., Fan, E., & Himburg, H. A. (2023). Cord Blood–Derived Endothelial Progenitor Cells Promote In Vivo Regeneration of Human Hematopoietic Bone Marrow. International Journal of Radiation Oncology*Biology*Physics, 116(5), 1163-1174. https://doi.org/10.1016/j.ijrobp.2023.02.007

Vancouver

Doan PL, Frei AC, Piryani SO, Szalewski N, Fan E, Himburg HA. Cord Blood–Derived Endothelial Progenitor Cells Promote In Vivo Regeneration of Human Hematopoietic Bone Marrow. International Journal of Radiation Oncology*Biology*Physics. 2023;116(5):1163-1174. doi:10.1016/j.ijrobp.2023.02.007

BibTeX
@article{Doan2023,
  author = {Doan, Phuong L and Frei, Anne C and Piryani, Sadhna O and Szalewski, Nathan and Fan, Elizabeth and Himburg, Heather A},
  title = {Cord Blood–Derived Endothelial Progenitor Cells Promote In Vivo Regeneration of Human Hematopoietic Bone Marrow},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2023},
  volume = {116},
  number = {5},
  pages = {1163--1174},
  doi = {10.1016/j.ijrobp.2023.02.007}
}
Kostenlos starten →